logo
  

Earnings Reported After The Bell June 9

Mattress Firm MFRM 061015

Here is a quick summary of the earnings reported after the bell on June 9. All these stocks listed below and many more have been researched already, and a few stocks have been short-listed as potential gainers. Click here to find out more...

1.Mattress Firm Holding Corp (MFRM)

First-quarter net earnings were $5.5 million or $0.15 per share compared with $7.7 million or $0.22 per share last year.

Excluding items, adjusted earnings for the quarter were $0.33 per share compared with $0.31 per share a year ago.

Revenues for the quarter were $562.6 million compared with $333.5 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $0.39 per share on revenues of $565.8 million for the quarter. Analysts' estimates typically exclude special items.

For the full year 2015, the company continues to expect adjusted earnings of $2.50 to $2.70 per share. It now expects revenues of $2.49 billion to $2.54 billion, up from prior guidance of $2.47 billion to $2.52 billion.

Analysts expect earnings of $2.62 per share on revenues of $2.49 billion for the year.

***

2.Limoneira Company (LMNR)

Q2 Net income applicable to common stock was $2.4 million or $0.17 per share compared to $2.0 million or $0.15 per share a year ago.

Q2 revenue was $28.3 million, compared to $24.8 million in the second quarter of the previous fiscal year.

Analysts expected the company to report net income of $0.14 per share on revenues of $25.66 million for the period.

FY Outlook

The company expects fiscal year 2015 earnings per diluted share to be in the range of $0.36 to $0.40, compared to previous guidance of $0.42 to $0.46; Consensus $0.45.

***

3.KMG Chemicals, Inc. (KMG)

Q3 net income was $2.14 million or $0.18 per share vs $1.23 million or $0.11 per share a year ago.

Q3 non-GAAP net income was $4.1 million or $0.35 per share vs $2.39 million or $0.20 per share a year ago.

Q3 net sales were $74.0 million vs $84.44 million a year ago.

Analysts expected the company to report net income of $0.12 per share on revenues of $77.05 million for the period.

FY Outlook

The company narrows its net sales forecast to approximately $320 million versus prior forecast of $315-325 million; Consensus $325.54 million.

***

4.Sigma Designs Inc (SIGM)

First-quarter net loss was $0.4 million or $0.01 per share compared with a loss of $9.9 million or $0.29 per share last year.

Excluding items, adjusted earnings for the quarter were $0.09 per share compared with a loss of $0.14 per share a year ago.

Revenues for the quarter were $55.9 million compared with $36.9 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $0.01 per share on revenues of $53.5 million for the quarter. Analysts' estimates typically exclude special items.

***

5.Synergetics USA, Inc. (SURG)

Q3 net income was $1.23 million or $0.05 per share vs $943000 or $0.04 per share a year ago.

Q3 Total sales were $19.4 million vs. $16.1 million a year ago.

Analysts expected the company to report net income of $0.04 per share on revenues of $19.16 million for the period.

***

6.Apigee (APIC)

Q3 net loss was $10.99 million or $2.16 per share vs net loss of $13.02 million or $3.64 per share a year ago.

Q3 revenue was $17.29 million vs $14.39 million a year ago.

Analysts expected the company to report net loss of $1.17 per share on revenues of $16.69 million for the period.

Q4 Outlook

Total revenue is expected to be in the range of $17.7 million to $18.3 million.

Non-GAAP net loss per share is expected to be in the range of $0.42 to $0.40.

Analysts expect the company to report net loss of $0.40 per share on revenues of $17.86 million for the period.

FY Outlook

Total revenue is expected to be in the range of $67.6 million to $68.2 million.

Non-GAAP net loss per share is expected to be in the range of $ 1.86 to $ 1.83.

Analysts expect the company to report net loss of $3.19 per share on revenues of $66.96 million for the period.

***

7.Enzo Biochem Inc. (ENZ)

Q3 Net loss was $(2.9) million, or $(0.06) per share compared to ($0.5) million or $(0.01) per share a year ago.

Q3 non-GAAP net loss was $(3.1) million or $0.07 per share compared to $(2.1) million or $0.05 per share a year ago.

Q3 Revenues were $23.99 million vs $23.98 million a year ago.

Analysts expected the company to report net loss of $0.06 per share on revenues of $24.4 million for the period.

***

8. Seneca Foods Corporation (SENEA)

Q4 net earnings were $2.8 million, or $0.26 per share, compared to a loss of $(1.0) million, or $(0.09) per share a year ago.

Net sales for the fourth quarter decreased 5.4% to $277.9 million from $293.76 million a year ago.

***

9. Streamline Health Solutions, Inc. (STRM)

Q1 net loss was $2.16 million or $0.12 per share vs net loss of $2.9 million or $0.16 per share a year ago.

Q1 Revenues decreased 11% to $6.17 million versus $6.95 million a year ago.

Analysts expected the company to report net loss of $0.12 per share on revenues of $7.47 million for the period.

***

10.Cellectis (CLLS)

Q1 Net income was of €6.3 million, or €0.23 per share vs net loss of €1.0 million, or €0.00 per share a year ago.

Q1 Adjusted net income was €7.1 million, or €0.23 per share.

Q1 total revenues and other income were of €9.2 million vs €26.5 million a year ago.

***

For comments and feedback contact: editorial@rttnews.com

Business News

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Follow RTT